CoChat

Metabolic Effects of Liothyronine Therapy in Hypothyroidism: A Randomized, Double-Blind, Crossover Trial of Liothyronine Versus Levothyroxine

Open access
Celi, Francesco S., Zemskova, Marina, Linderman, Joyce D., Smith, Sheila, Drinkard, Bart, Sachdev, Vandana, Skarulis, Monica C., Kozlosky, Merel, Csako, Gyorgy, Costello, Rene, Pucino, Frank · 2011 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

CONTEXT: Levothyroxine (L-T(4)) therapy is based on the assumption that the conversion of T(4) into T(3) provides adequate amounts of active hormone at target tissues. However, in rodents, L-T(4) alone does not restore a euthyroid state in all tissues. Previous combination L-T(4)/liothyronine (L-T(3)) therapy trials focused on quality-of-life endpoints, and limited information is available on the effects on other measures of thyroid hormone action. OBJECTIVE: Our objective was to evaluate the efficacy of thyroid hormone replacement with L-T(4) or L-T(3) at doses producing equivalent normalization of TSH. PARTICIPANTS, DESIGN, AND SETTING: Fourteen hypothyroid patients participated in this randomized, double-blind, crossover intervention at the National Institutes of Health Clinical Center. INTERVENTIONS: L-T(3) or L-T(4) were administered thrice daily to achieve a target TSH from 0.5-1.5 mU/liter. Volunteers were studied as inpatients after 6 wk on a stable dose and at the target TSH. MAIN OUTCOME MEASURES: Serum thyroid hormones, lipid parameters, and indices of glucose metabolism were evaluated. RESULTS: No difference was observed in TSH between L-T(3) and L-T(4) treatments. L-T(3) resulted in significant weight loss [L-T(4), 70.6 ± 12.5, vs. L-T(3), 68.5 ± 11.9 kg (P = 0.009)] and in a 10.9 ± 10.0% decrease in total cholesterol (P = 0.002), 13.3 ± 12.1% decrease in low-density lipoprotein-cholesterol (P = 0.002), and an 18.3 ± 28.6% decrease in apolipoprotein B (P = 0.018). No significant differences were observed in high-density lipoprotein-cholesterol, heart rate, blood pressure, exercise tolerance, or insulin sensitivity. CONCLUSIONS: The substitution of L-T(3) for L-T(4) at equivalent doses (relative to the pituitary) reduced body weight and resulted in greater thyroid hormone action on the lipid metabolism, without detected differences in cardiovascular function or insulin sensitivity.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2011-1329

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Cited by

See all 135

Metadata

Authors
Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., & Pucino, F.
Affiliations
  • National Institutes of Health (US)
  • National Heart, Lung, and Blood Institute (US)
Corresponding author
Celi, Francesco S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-11
Volume
96
Issue
11
Pages
3466-3474
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2057697685
Cited by
125
References
48
Citations by year
2026: 3 · 2025: 8 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 14 · 2017: 9 · 2016: 8 · 2015: 3 · 2014: 13 · 2013: 11 · 2012: 13
FWCI
10.48
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (Z01-DK047057-02, Z01DK047057)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
liothyronine, levothyroxine, hypothyroidism, thyroid hormone replacement, lipid metabolism, cholesterol, apolipoprotein B, weight loss, insulin sensitivity, thyroid-stimulating hormone, cardiovascular function, exercise tolerance, glucose metabolism, thyroid hormone action, crossover trial, apolipoprotein A-I, apolipoprotein C
MeSH terms
Adult, Aged, Apolipoproteins B, Body Composition, Cholesterol, Double-Blind Method, Drug Administration Schedule, Female, Humans, Hypothyroidism, Male, Middle Aged, Quality of Life, Thyroid Hormones, Thyroxine, Triiodothyronine, Bone Density, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.